
NASDAQHealthcareMedical - Devices
ข้อมูลล่าสุด
US$5.43
+US$0.07 · +1.31%
Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to differentiate between various fluorescent tags on individual cells. Complementing these, the Aurora Cell Sorter system utilizes full spectrum profiling technology to broaden the range of potential applications in cell analysis. Beyond instrumentation, Cytek provides essential reagents and kits. These include cFluor reagents, which are antibodies conjugated with fluorochromes, specifically designed to identify target cells for analysis on their systems. They also offer a 25-color immunoprofiling assay, a ready-to-use solution for pinpointing major human immune cell subpopulations like TBNK cells, monocytes, dendritic cells, and basophils. To streamline laboratory operations, the company offers automated micro-sampling and sample loader systems. These automated plate loaders are engineered to integrate seamlessly with the Aurora and Northern Lights systems. The intuitive SpectroFlo software accompanies these systems, simplifying the workflow from quality control through to data analysis. Cytek also provides comprehensive customer support resources. Cytek's diverse client base includes pharmaceutical and biopharmaceutical companies, academic research institutions, and clinical research organizations. The company distributes its products through a direct sales force and dedicated support teams in North America, Europe, China, and the Asia-Pacific region. Additionally, it partners with distributors and sales agents to serve markets across European, Latin American, Middle Eastern, and other Asia-Pacific countries. Originally established in 1992 as Cytoville, Inc., the company officially adopted the name Cytek Biosciences, Inc. in August 2015. Its corporate headquarters are situated in Fremont, California.
ราคาปิดก่อนหน้า
US$5.43
+US$0.07 · +1.31%
เวลาในวันใช้เขตเวลาET ข้อมูลตลาดอาจล่าช้า
Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to differentiate between various fluorescent tags on individual cells. Complementing these, the Aurora Cell Sorter system utilizes full spectrum profiling technology to broaden the range of potential applications in cell analysis. Beyond instrumentation, Cytek provides essential reagents and kits. These include cFluor reagents, which are antibodies conjugated with fluorochromes, specifically designed to identify target cells for analysis on their systems. They also offer a 25-color immunoprofiling assay, a ready-to-use solution for pinpointing major human immune cell subpopulations like TBNK cells, monocytes, dendritic cells, and basophils. To streamline laboratory operations, the company offers automated micro-sampling and sample loader systems. These automated plate loaders are engineered to integrate seamlessly with the Aurora and Northern Lights systems. The intuitive SpectroFlo software accompanies these systems, simplifying the workflow from quality control through to data analysis. Cytek also provides comprehensive customer support resources. Cytek's diverse client base includes pharmaceutical and biopharmaceutical companies, academic research institutions, and clinical research organizations. The company distributes its products through a direct sales force and dedicated support teams in North America, Europe, China, and the Asia-Pacific region. Additionally, it partners with distributors and sales agents to serve markets across European, Latin American, Middle Eastern, and other Asia-Pacific countries. Originally established in 1992 as Cytoville, Inc., the company officially adopted the name Cytek Biosciences, Inc. in August 2015. Its corporate headquarters are situated in Fremont, California.
ช่วงราคารายวัน
ปัจจุบัน US$5.43
ช่วง 52 สัปดาห์
ปัจจุบัน US$5.43
เวลาในวันใช้เขตเวลาET ข้อมูลตลาดอาจล่าช้า
คะแนน GoAI
ถือ
มูลค่า
47
มูลค่ายุติธรรม
ความเชื่อมั่น
62
เชิงบวก
ความเสี่ยง
55
ความเสี่ยงค่อนข้างสูง
โมเมนตัม
50
เป็นกลาง
งานวิจัย GoAI ฉบับเต็ม
ดูข้อมูลสนับสนุน ปัจจัยหนุน และความเสี่ยงในเชิงลึก
Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to differentiate between various fluorescent tags on individual cells. Complementing these, the Aurora Cell Sorter system utilizes full spectrum profiling technology to broaden the range of potential applications in cell analysis. Beyond instrumentation, Cytek provides essential reagents and kits. These include cFluor reagents, which are antibodies conjugated with fluorochromes, specifically designed to identify target cells for analysis on their systems. They also offer a 25-color immunoprofiling assay, a ready-to-use solution for pinpointing major human immune cell subpopulations like TBNK cells, monocytes, dendritic cells, and basophils. To streamline laboratory operations, the company offers automated micro-sampling and sample loader systems. These automated plate loaders are engineered to integrate seamlessly with the Aurora and Northern Lights systems. The intuitive SpectroFlo software accompanies these systems, simplifying the workflow from quality control through to data analysis. Cytek also provides comprehensive customer support resources. Cytek's diverse client base includes pharmaceutical and biopharmaceutical companies, academic research institutions, and clinical research organizations. The company distributes its products through a direct sales force and dedicated support teams in North America, Europe, China, and the Asia-Pacific region. Additionally, it partners with distributors and sales agents to serve markets across European, Latin American, Middle Eastern, and other Asia-Pacific countries. Originally established in 1992 as Cytoville, Inc., the company officially adopted the name Cytek Biosciences, Inc. in August 2015. Its corporate headquarters are situated in Fremont, California.
ช่วงราคารายวัน
ปัจจุบัน US$5.43
ช่วง 52 สัปดาห์
ปัจจุบัน US$5.43
อัตรากำไรที่รายงานในช่วงเวลาที่มีอยู่
รายได้
รายได้จากการดำเนินงาน
รายได้สุทธิ
| รายการ (USD) | ปีงบประมาณ 2025 | ปีงบประมาณ 2024 | ปีงบประมาณ 2023 | ปีงบประมาณ 2022 | ปีงบประมาณ 2021 |
|---|---|---|---|---|---|
| รายได้ | 201.49M USD | 200.45M USD | 193.02M USD | 164.04M USD | 127.95M USD |
| ต้นทุนสินค้าขาย | 97.03M USD | 89.35M USD | 83.59M USD | 63.06M USD | 48.81M USD |
| กำไรขั้นต้น | 104.46M USD | 111.11M USD | 109.43M USD | 100.97M USD | 79.14M USD |
| การวิจัยและพัฒนา | 36.47M USD | 39.4M USD | 44.15M USD | 34.86M USD | 24.44M USD |
| การขาย ทั่วไป และธุรการ | 108.38M USD | 92.23M USD | 93.12M USD | 67.92M USD | 45.55M USD |
| ค่าใช้จ่ายในการดำเนินงาน | 144.84M USD | 131.63M USD | 137.27M USD | 102.78M USD | 69.99M USD |
| รายได้ดอกเบี้ย | 2.22M USD | 10.36M USD | 6.41M USD | 4.62M USD | 49K USD |
| ดอกเบี้ยจ่าย | 474K USD | — | 2.07M USD | 2.57M USD | 1.74M USD |
| ค่าเสื่อมราคาและค่าตัดจำหน่าย | 11.98M USD | 10.49M USD | 9.23M USD | 5.66M USD | 1.24M USD |
| รายได้จากการดำเนินงาน | −40.38M USD | −20.52M USD | −27.85M USD | −1.8M USD | 9.16M USD |
| รายได้สุทธิ | −66.54M USD | −6.02M USD | −12.15M USD | 2.58M USD | 3M USD |
ข้อเท็จจริงของบริษัทได้รับการปรับปรุง 11 ต.ค. 2569.
ผลประกอบการล่าสุดที่ประกาศ
ผลประกอบการล่าสุดที่ประกาศ
ประมาณการของนักวิเคราะห์ภายนอกอาจเปลี่ยนแปลงและไม่ใช่คำแนะนำของ GoAI
เป้าหมายเฉลี่ย
US$4.88
โอกาสปรับลง 10.13%กองทุนซื้อขายแลกเปลี่ยนที่รายงานความเสี่ยงต่อหุ้นนี้
iShares Russell 2000 ETFIWM17.33M0.02%78.74B USD0.19%US$278.94+0.49%
Vanguard Morningstar Total Stock Market ETFVTI16.85M0.00%2.3T USD0.03%US$381.94+0.63%
Vanguard Extended Market ETFVXF6.2M0.01%95.4B USD0.05%US$235+0.80%
iShares Biotechnology ETFIBB5.03M0.05%10.82B USD0.44%US$206.49+3.00%
Dimensional - US Small Cap ETFDFAS4.6M0.01%33.87B USD0.31%US$78.35+0.32%
Vanguard Russell 2000 ETFVTWO3.34M0.02%18B USD0.06%US$112.66+0.50%
Schwab U.S. Small-Cap ETFSCHA3.23M0.01%21.82B USD0.03%US$32.79+0.40%
Fidelity Enhanced Small Cap ETFFESM3.19M0.05%6.41B USD0.28%US$45.46+0.46%
iShares Russell 2000 ETFIWM
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
iShares Biotechnology ETFIBB
Dimensional - US Small Cap ETFDFAS
Vanguard Russell 2000 ETFVTWO
Schwab U.S. Small-Cap ETFSCHA
Fidelity Enhanced Small Cap ETFFESMเนื้อหาที่สร้างโดย AI และข้อมูลตลาดที่ล่าช้ามีไว้เพื่อให้ข้อมูลและการศึกษาเท่านั้น ไม่ใช่คำแนะนำการลงทุน